This may affect you - so read this! Brain tumor patients are usually given a drug to help prevent stomach problems from the steroids they use. Most commonly it is a proton pump inhibitor such as
This letter to the editor to Neuro-Oncology practice raises a very serious issue. These drugs may cause resistance to Temodar (Temozolomide) by increasing the levels of an enzyme called ALDH1A1. If this enzyme is high, the average survival for a patient with a methylated MGMT GBM is 14.6 months compared to 32.9 months if the enzyme is low. For Unmethylated MGMT, the numbers are 12.6 vs 21.4 months. This is a HUGE difference.
This has not been tested in a GBM trial, but it raises a red flag when considering these drugs, especially when there are easy alternatives. Instead of the drugs listed above, H3 blockers, such as